{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:21:05Z","timestamp":1778642465202,"version":"3.51.4"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Brucellosis is a widespread zoonotic disease that poses a considerable challenge to global public health. Existing diagnostic methods for this condition, such as serological assays and bacterial culture, encounter difficulties due to their limited specificity and high operational complexity. Therefore, there is an urgent need for the development of enhanced diagnostic approaches for brucellosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Tandem mass tag (TMT) proteomic analysis was conducted on the wild-type strain <jats:italic>Brucella abortus<\/jats:italic> (<jats:italic>B. abortus<\/jats:italic>) DT21 and the vaccine strain <jats:italic>B. abortus<\/jats:italic> A19 to identify proteins with high expression levels. The proteins that exhibited high expression in the wild-type strain were selected based on the proteomic results. Subsequently, B-cell linear epitopes were predicted using multiple computational tools, including ABCpred, SVMTriP, BCPred, and Bepipred Linear Epitope Prediction 2.0. These epitopes were concatenated to construct a multiepitope fusion protein. Following prokaryotic expression and purification, an indirect enzyme-linked immunosorbent assay (iELISA) was developed. A total of 100 positive serum samples, 96 negative serum samples, and 40 serum samples from patients infected with other pathogens were collected and analyzed using the established iELISA. Furthermore, the protein was assessed for its capability to differentiate human brucellosis from lipopolysaccharide (LPS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Proteomic analysis revealed the presence of 152 proteins with high expression levels in the wild-type strains. A multiepitope fusion protein, comprising a total of 32 predicted B-cell linear epitopes, was successfully prepared. The results from the iELISA indicated that the multiepitope fusion protein exhibited exceptional diagnostic performance, evidenced by an area under the receiver operating characteristic curve (AUC) of 0.9576, a sensitivity of 0.9300, and a specificity of 0.8542. In comparison to the commonly utilized LPS antigen, the fusion protein demonstrated a reduced level of cross-reactivity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A novel multiepitope fusion protein has been successfully developed utilizing bioinformatics and TMT proteomics technology. This fusion protein demonstrates significant potential as a diagnostic antigen for brucellosis, exhibiting high sensitivity and specificity.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1509534","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T05:10:41Z","timestamp":1736485841000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Preparation and application of a Brucella multiepitope fusion protein based on bioinformatics and Tandem Mass Tag-based proteomics technology"],"prefix":"10.3389","volume":"15","author":[{"given":"Qi","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meixue","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dehui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70382-6","article-title":"The new global map of human brucellosis","volume":"6","author":"Pappas","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2302.151710","article-title":"Changing epidemiology of human brucellosis, China, 1955-2014","volume":"23","author":"Lai","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"B3","unstructured":""},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70286-4","article-title":"Human brucellosis","volume":"7","author":"Franco","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3325\/cmj.2010.51.296","article-title":"Diagnosis of brucellosis in livestock and wildlife","volume":"51","author":"Godfroid","year":"2010","journal-title":"Croat Med J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2010.06.014","article-title":"Update on laboratory diagnosis of human brucellosis","author":"Araj","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00073-19","article-title":"Laboratory diagnosis of human brucellosis","volume":"33","author":"Yagupsky","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.12834\/VetIt.1176.6539.2","article-title":"Cross-reactivity in serological tests for brucellosis: a comparison of immune response of Escherichia coli O157:H7 and Yersinia enterocolitica O:9 vs Brucella spp","volume":"54","author":"Bonfini","year":"2018","journal-title":"Vet Ital"},{"key":"B9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1017\/S0950268800049529","article-title":"The serological relationship between Escherichia coli O157 and Yersinia enterocolitica O9 using sera from patients with brucellosis","volume":"108","author":"Chart","year":"1992","journal-title":"Epidemiol Infect"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2014.11.003","article-title":"An overview of bioinformatics tools for epitope prediction: implications on vaccine development","volume":"53","author":"Soria-Guerra","year":"2015","journal-title":"J BioMed Inform"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2010.08.006","article-title":"An integrated bioinformatics approach to the characterization of influenza A\/H5N1 viral sequences by microarray data: Implication for monitoring H5N1 emerging strains and designing appropriate influenza vaccines","volume":"24","author":"Kaewpongsri","year":"2010","journal-title":"Mol Cell Probes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007245","article-title":"Bioinformatics and structural characterization of a hypothetical protein from Streptococcus mutans: implication of antibiotic resistance","volume":"4","author":"Nan","year":"2009","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.2c02742","article-title":"TMT-Based Quantitative Proteomics Analyses Reveal the Antibacterial Mechanisms of Anthocyanins from Aronia melanocarpa against Escherichia coli O157:H7","volume":"70","author":"Deng","year":"2022","journal-title":"J Agric Food Chem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/gzn075","article-title":"COBEpro: a novel system for predicting continuous B-cell epitopes","volume":"22","author":"Sweredoski","year":"2009","journal-title":"Protein engineering design selection: PEDS"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1745-7580-2-2","article-title":"Improved method for predicting linear B-cell epitopes","volume":"2","author":"Larsen","year":"2006","journal-title":"Immunome Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60327-241-4_19","article-title":"Protein secondary structure prediction","volume":"609","author":"Pirovano","year":"2010","journal-title":"Methods Mol Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/978-1-0716-0389-5_17","article-title":"SVMTriP: A method to predict B-cell linear antigenic epitopes","volume":"2131","author":"Yao","year":"2020","journal-title":"Methods Mol Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.5455\/OVJ.2024.v14.i5.1","article-title":"Brucellosis: Unveiling the complexities of a pervasive zoonotic disease and its global impacts","volume":"14","author":"Khairullah","year":"2024","journal-title":"Open Vet J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"922","DOI":"10.15252\/msb.20167062","article-title":"Proteomics and integrative omic approaches for understanding host-pathogen interactions and infectious diseases","volume":"13","author":"Jean Beltran","year":"2017","journal-title":"Mol Syst Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/proteomes8020008","article-title":"Proteomics of brucella","volume":"8","author":"Poetsch","year":"2020","journal-title":"Proteomes"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2013.02.017","article-title":"Inactivation of the ABC transporter ATPase gene in Brucella abortus strain 2308 attenuated the virulence of the bacteria","volume":"164","author":"Zhang","year":"2013","journal-title":"Vet Microbiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"104345","DOI":"10.1016\/j.micpath.2020.104345","article-title":"Immunoproteomics of Brucella abortus reveals potential of recombinant antigens for discriminating vaccinated from naturally infected cattle","volume":"147","author":"Faria","year":"2020","journal-title":"Microb Pathog"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetimm.2014.05.009","article-title":"Immunoproteomics of Brucella abortus RB51 as candidate antigens in serological diagnosis of brucellosis","volume":"160","author":"Kim","year":"2014","journal-title":"Vet Immunol Immunopathol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jim.2005.11.003","article-title":"Immunoproteomic characterization of Brucella abortus 1119-3 preparations used for the serodiagnosis of Brucella infections","volume":"309","author":"Al Dahouk","year":"2006","journal-title":"J Immunol Methods"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1996.0241","article-title":"Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized Guinea pigs","volume":"172","author":"Oliveira","year":"1996","journal-title":"Cell Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.07.002","article-title":"Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB\/c mice","volume":"25","author":"Delpino","year":"2007","journal-title":"Vaccine"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0147-9571(96)00036-7","article-title":"Role of immune responses to a GroEL heat shock protein in preventing brucellosis in mice vaccinated with Brucella abortus strain RB51","volume":"20","author":"Stevens","year":"1997","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1135(00)00231-5","article-title":"Humoral immune response of BALB\/c mice to a vaccinia virus recombinant expressing Brucella abortus GroEL does not correlate with protection against a B. abortus challenge","volume":"76","author":"Baloglu","year":"2000","journal-title":"Vet Microbiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"106874","DOI":"10.1016\/j.mimet.2023.106874","article-title":"Use of recombinant malate dehydrogenase (MDH) and superoxide dismutase (SOD) [CuZn] as antigens in indirect ELISA for diagnosis of bovine brucellosis","author":"Andrade","year":"2024","journal-title":"J Microbiol Methods"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.micpath.2017.06.019","article-title":"Th2-related immune responses by the Brucella abortus cellular antigens, malate dehydrogenase, elongation factor, and arginase","volume":"110","author":"Im","year":"2017","journal-title":"Microb Pathog"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4142\/jvs.2016.17.1.119","article-title":"Molecular cloning, purification and immunogenicity of recombinant Brucella abortus 544 malate dehydrogenase protein","volume":"17","author":"Reyes","year":"2016","journal-title":"J Vet Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00125","article-title":"Immunogenicity of a multi-epitope DNA vaccine encoding epitopes from cu-zn superoxide dismutase and open reading frames of brucella abortus in mice","volume":"8","author":"Escalona","year":"2017","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24073","article-title":"Overexpression of Cu-Zn SOD in Brucella abortus suppresses bacterial intracellular replication via down-regulation of Sar1 activity","volume":"9","author":"Liu","year":"2018","journal-title":"Oncotarget"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1148233","article-title":"Phenotypes controlled by the Brucella abortus two component system BvrR\/BvrS are differentially impacted by BvrR phosphorylation","volume":"14","author":"Altamirano-Silva","year":"2023","journal-title":"Front Microbiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.05321-11","article-title":"Extended safety and efficacy studies of the attenuated Brucella vaccine candidates 16 M(Delta)vjbR and S19(Delta)vjbR in the immunocompromised IRF-1-\/- mouse model","volume":"19","author":"Arenas-Gamboa","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01017-08","article-title":"The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB\/c mice when delivered in a sustained-release vehicle","volume":"77","author":"Arenas-Gamboa","year":"2009","journal-title":"Infect Immun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1509534\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T05:10:45Z","timestamp":1736485845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1509534\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2024.1509534"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1509534","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"article-number":"1509534"}}